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Summary
Nicotinamide adenine dinucleotide (NAD) is an essen-
tial cofactor for cellular redox reactions and can act as
an important substrate in numerous biological pro-
cesses. As a result, nature has evolved multiple bio-
synthetic pathways to meet this high chemical de-
mand. In Saccharomyces cerevisiae, the NAD salvage
pathway relies on the activity of nicotinic acid phos-
phoribosyltransferase (NAPRTase), a member of the
phosphoribosyltransferase (PRTase) superfamily. Here,
we report the structure of a eukaryotic (yeast) NAPRTase
at 1.75 Å resolution (locus name: YOR209C, gene
name: NPT1). The structure reveals a two-domain fold
that resembles the architecture of quinolinic acid
phosphoribosyltransferases (QAPRTases), but with
completely different dispositions that provide evi-
dence for structural heterogeneity among the Type II
PRTases. The identification of a third domain in
NAPRTases provides a structural basis and possible
mechanism for the functional modulation of this fam-
ily of enzymes by ATP.
Introduction
Nicotinamide adenine dinucleotide (NAD) is a versatile
compound that participates in a host of biological func-
tions. Acting as an electron shuttle, it serves as an
essential cofactor for cellular redox reactions and en-
ergy metabolism (Rizzi and Schindelin, 2002). Addition-
ally, NAD can be utilized as a consumable substrate to
modulate other significant biological activities, includ-
ing transcriptional regulation, DNA damage response,
and neuroprotection (Pappas et al., 2004; Buck et al.,
2004; Muiras, 2003; Araki et al., 2004). Enzymes that
employ NAD in this fashion include the Sir2 family of
protein deacetylases (Sirtuins) and poly(ADP-ribose)
polymerases (PARPs). To sustain these demanding
chemical roles, organisms must maintain a constant*Correspondence: stevens@scripps.edu
5 These authors contributed equally to this work.reservoir of NAD. In most cases, including in humans
and in yeast, NAD replenishment is primarily achieved
through de novo biosynthesis (Figure 1, black). The ini-
tial step of this pathway is catalyzed by quinolinic acid
phosphoribosyltransferase (QAPRTase), which forms
the NAD precursor nicotinic acid mononucleotide (NAMN)
from the tryptophan metabolite quinolinic acid (QA). Al-
ternatively, NAD can be synthesized from NA via the
Preiss-Handler pathway (Preiss and Handler, 1958a,
1958b) (Figure 1, dashed blue). This series of reactions
helps facilitate the dietary uptake of NA by converting
it to the usable substrate NAMN, the point of con-
vergence with the de novo pathway. Salvage pathways,
which recover NAD from its degradation product nico-
tinamide (NM), also exist (Katoh and Hashimoto, 2004).
Organisms that contain nicotinamide deaminase, such
as yeast and E. coli, are able to convert NM back to
NA and exploit the Preiss-Handler pathway for salvage
purposes (Figure 1, solid blue). Vertebrates, however,
lack this enzyme, and their NAD salvage functions are
dependent on the activity of nicotinamide phosphori-
bosyltransferase (NMPRTase). This salvage route recy-
cles NAD through the intermediate nicotinamide mono-
nucleotide (NMN) (Figure 1, red). Other bacteria, such
as Haemophilus influenza, lack the enzymes of the
aforementioned pathways and, instead, use an al-
ternate biosynthetic mechanism involving ribosyl nico-
tinamide (RN) and NMN, a process shown to be present
in eukaryotes as well (Bieganowski and Brenner, 2004)
(Figure 1, green).
In the yeast Saccharomyces cerevisiae, the NAD sal-
vage pathway relies on the activity of NAPRTase. As
a member of the phosphoribosyltransferase (PRTase)
superfamily, this enzyme employs 5#-phosphoribosyl-
1#-pyrophosphate (PRPP) as a substrate to catalyze
the first reaction in the Preiss-Handler pathway:
NA + PRPP ⇌ NAMN + PPi
The rate of this reaction is quite slow at 0.3 s−1, ren-
dering this enzyme thoroughly inefficient on its own. To
circumvent this problem, NAPRTases couple ATP hy-
drolysis to their transferase activity, thereby increasing
the catalytic turnover to 500 s−1 (Gross et al., 1998;
Grubmeyer et al., 1999). This stimulation occurs through
the phosphorylation of a specific, conserved histidine
residue in a process that thus far appears to be unique
to the NAPRTase family. Mutational studies indicate
that changing this residue completely abrogates both
autophosphorylation and ATP-dependent stimulation
(Gross et al., 1996; Rajavel et al., 1998). This implies
that NAPRTases are subject to three competing reac-
tions at any one time: basal catalysis, stimulated catal-
ysis, and ATP hydrolysis.
In spite of this well-understood kinetic scheme, a de-
tailed description of NAPRTase structure has remained
elusive. A number of other PRTases have been deter-
mined at high resolution and have revealed distinct
structural classes based on overall fold and conserved
Structure
1386Figure 1. NAD Biosynthetic Pathways
Solid black arrows indicate the de novo biosynthesis pathway, dashed blue arrows indicate the Preiss-Handler pathway, the solid blue arrow
indicates the salvage route using nicotinamide deaminase, solid red arrows indicate the NMPRTase-dependent salvage pathway, and solid
green arrows indicate the nicotinamide riboside pathway. For each step in the reaction scheme, PDB codes and structures are provided
(where applicable). Boxed molecules represent major metabolic substrates/products. Abbreviations are as follows: QA, quinolinic acid; NA,
nicotinic acid; NAMN, nicotinic acid mononucleotide; NAD, nicotinamide adenine dinucleotide; NM, nicotinamide; NMN, nicotinamide mono-
nucleotide; RN, ribosyl nicotinamide; PRPP, 5#-phosphoribosyl-1#-pyrophosphate; PRTase, phosphoribosyltransferase; ATase, adenylyltrans-
ferase.characteristics. Type I PRTases contain a five-stranded,
parallel β sheet surrounded by α helices (the “PRTase
fold”) and a common PRPP binding motif (Vos et al.,
1997). Type II PRTases, represented in the Protein Data
Bank (PDB) by several bacterial QAPRTases, exhibit an
irregular seven-stranded α/β barrel and an N-terminal
open-faced sandwich. Members of this group lack the
conserved PRPP binding site and instead have a phos-
phate binding motif that resembles that of unrelated
enzymes (Eads et al., 1997; Sharma et al., 1998;
Schwarzenbacher et al., 2004). Other structural exam-
ples outside the Type I/Type II PRTase framework in-
clude the anthranilate PRTase, with a two-domain fold
that encompasses a seven-stranded mixed β sheet
(Mayans et al., 2002; Kim et al., 2002), and the ATP
PRTase, comprised of three continuous domains that
each contain a β sheet surrounded by α helices (Cho
et al., 2003). From sparse sequence conservation, it has
been suggested that NAPRTase architecture is akin to
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fhat of the QAPRTases, which would classify it as a
ype II PRTase (Rajavel et al., 1998). More recently, the
tructure of the Thermoplasma acidophilum NAPRTase
as also reported (Shin et al., 2005).
In this work, we have used X-ray crystallography to
etermine the structure of the NAPRTase from Saccha-
omyces cerevisiae (yNAPRTase) at 1.75 Å resolution.
o our knowledge, this structure represents the first
igh-resolution view of a eukaryotic Type II enzyme and
he second published example of an NAPRTase structure
Shin et al., 2005). The two-domain fold of yNAPRTase
onfirms a general similarity to QAPRTases; however,
he barrel and sandwich domains occupy different
elative dispositions to one another, permitting the
APRTase to exist in an alternative oligomeric state.
e have further analyzed residue, domain, and site
onservation among Type II PRTases, as well as phylo-
enetic and structural relationships within this enzyme
amily. These combined data suggest a possible molec-
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1387ular evolution mechanism that can contribute to our un-
derstanding of the evolution of NAD biosynthetic and
salvage pathways.
Results and Discussion
Structure of NAPRTase
Native yNAPRTase is a 430 residue protein with a calcu-
lated molecular mass of 49 kDa. The final model con-
tains four protein monomers in the asymmetric unit
(designated as molecules A, B, C, and D), each contain-
ing residues 1–415 (B and C extend to 419 and 416,
respectively). The four individual monomers are struc-
turally equivalent and superimpose with an average
rmsd of 0.33 Å when aligned with the multiple structural
alignment program MASS (Dror et al., 2003). The Mat-
thews’ coefficient, Vm (Matthews, 1968), for yNAPRTase
is 2.29 Å3/Da, and the estimated solvent content is
45.8%. According to the Ramachandran plot, 91.2% of
the residues fall within the most favored regions, while
the remaining 8.8% occupy additionally allowed re-
gions. A summary of the crystal parameters, data col-
lection, and refinement statistics are outlined in Table 1
(see Experimental Procedures).Table 1. Summary of Crystal Parameters, Data Collection, and Refinement Statistics for yNAPRTase
λ0Se λ1MADSe λ2MADSe
Data Collection
Space group P1 P1 P1
Unit cell parameters a = 54.406 Å, b = 83.103 Å, a = 54.706 Å, b = 83.143 Å, a = 54.406 Å, b = 83.103 Å,
c = 107.237 Å, α = 97.35°, c = 107.502 Å, α = 97.29°, c = 107.237 Å, α = 97.35°,
β = 95.67°, γ = 97.99° β = 95.01°, γ = 97.88° β = 95.67°, γ = 97.99°
Wavelength (Å) 0.96860 0.97980 1.0332
Resolution range (Å) 50.00–1.75 50.00–2.02 50.00–2.13
Number of observations (>1) 667,108 439,886 383,937
Number of reflections 177,740 118,673 101,313
Completeness (%) 96.8 97.5 97.5
Mean I/σ(I) 10.1 8.1 9.9
Rsym on I 0.075 0.118 0.104
Sigma cutoff 0.0 0.0 0.0
Highest-resolution shell (Å) 1.81–1.75 2.09–2.02 2.21–2.13
Model and Refinement Statistics
Data set used in refinement λ0Se
Cutoff criteria |F| > 0
Rcryst 0.1696
Rfree 0.2096
Resolution range (Å) 48.22–1.75
Number of reflections (total) 168,817
Number of reflections (test) 8,921
Completeness (% total) 96.2
Stereochemical Parameters
Restraints (rms observed)
Bond length 0.018 Å
Bond angle 1.54°
Average isotropic B value 8.5 Å2
ESU based on R value 0.112 Å
Protein residues/atoms 1671/13,455
Solvent molecules 1,272
Atomic coordinates and experimental structure factors of yNAPRTase have been deposited with the PDB and are accessible under the code
1VLP. High resolution data set (λ0Se) and MAD data sets (λ1MADSe and λ2MADSe) were collected on two separate crystals. ESU = estimated
overall coordinate error (CCP4, 1994; Tickle et al., 1998). Rsym = Σ|Ii − <Ii>|/Σ|Ii|, where Ii is the scaled intensity of the ith measurement, and
<Ii> is the mean intensity for that reflection. Rcryst = Σ||Fobs| − |Fcalc||/Σ|Fobs|, where Fcalc and Fobs are the calculated and observed structure
factor amplitudes, respectively. Rfree = as for Rcryst, but for 5.0% of the total reflections chosen at random and omitted from refinement.The overall architecture of each yNAPRTase mono-
mer consists of 13 β strands, 19 α helices, and two 310
helical segments (H3 and H15) (Figures S1A and S1B;
see the Supplemental Data available with this article
online). These elements are organized into two do-
mains: a discontinuous open-faced α + β sandwich,
and an irregular α/β barrel (Figure 2A). The β sandwich
domain is composed of the N-terminal residues 2–148
and an additional segment that flanks the barrel domain
on the C-terminal edge (residues 360–383). The upper
portion of the fold is an antiparallel β sheet (strands β1,
β2, β3, β12), which rests atop a helical assembly (H1–8)
that closes the barrel. This sandwich arrangement is a
common feature among glycosyltransferases. Domain
B (residues 149–359, shown in cyan in Figure 2A), in
contrast, has a barrel design that is shared only with
members of the QAPRTase family. Eight helices (H9,
H10, H12–H14, H16, H18, and H19) line the perimeter
of the barrel core, which is composed of strands β4–
β9. A gap exists between the second and third strands,
causing an irregular distribution of the barrel compo-
nents around the central axis. An additional structural
element, domain C (shown in magenta in Figure 2A),
extends from the final β strand of the sandwich region
Structure
1388Figure 2. Structure and Active Site of yNAPRTase
(A) Top and side views of the yNAPRTase monomer. Domains A, B, and C are colored red, cyan, and magenta, respectively.
(B) Magnified view of a bound phosphate molecule. The phosphate molecule is colored in red. Side chains participating in hydrogen bonding
(S329 and T355) are depicted in yellow, while those involved in van der Waals interactions (D328 and G354) are shown in green and blue.
Three-dimensional rendering generated with Accelrys Discovery Studio ViewerPro 5.0.
(C) Comparison of bound phosphate in yNAPRTase (left) with the M. tuberculosis QAPRTase active site (right; nicotinate mononucleotide
substrate). The binding interactions are shown in two dimensions via Ligplot; dashed lines represent hydrogen bonds, and semi-circles with
straight lines denote van der Waals interactions.and constitutes a novel feature thus far only observed
in NAPRTases. This C-terminal appendage (residues
383–415) contains a short β strand (β13), a long un-
structured coiled region, and an α helix. Markedly ab-
sent in this arrangement are the “PRTase fold” and the
conserved binding motif common to Type I PRTases.
Since the classification of PRTases reflects shared
structural features, the observed structural similarity to
QAPRTases, the archetypal Type II enzymes, implicates
yNAPRTase as another unique example of a Type II
PRTase.
Active Site Conservation
In the yNAPRTase crystal, a single phosphate molecule
is bound to each protein monomer. The ligand is posi-
tioned above β9 in the barrel domain and hydrogen
bonds with the backbone amides of S329 and T355.
Additional van der Waals contacts are made by D328
and G354 (Figures 2B and 2C, left). Sequence align-
ment shows that three of these side chains (D328,
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(354, and T355) are absolutely conserved across the
ntire NAPRTase family. Since phosphate alone is not
functional substrate of the NAPRTase enzyme, it is
ifficult to define unambiguously the active site of
NAPRTase. However, the positioning of this molecule
n the barrel domain helps to establish a contextual
ramework for the catalytic center via comparison with
ther Type II PRTases. Figure 2C (right) illustrates the
ey binding interactions in the Mycobacterium tubercu-
osis QAPRTase (PDB: 1QPR) (Sharma et al., 1998). This
tructure contains bound PRPP and QA analogs, which
re situated across the top of the barrel core and are
oordinated by loop residues, waters, and metal ions.
hen this assembly is juxtaposed with comparable re-
ions in yNAPRTase, the 5#-phosphate of PRPP coin-
ides with the location of the free phosphate, thereby
efining the lower edge of the NAPRTase active site.
his same position is occupied by a lone sulfate ion in
he apo structure of the M. tuberculosis QAPRTase
PDB: 1QPO) (Figure S4). Through this structural align-
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1389ment, one might expect that the unoccupied area near
the upper perimeter of the yNAPRTase barrel would
contain the NA binding site. In the yNAPRTase crystal,
this region (between β12 and H13) contains a solvent-
filled cavity occupied by several ordered water mole-
cules (Figures S4A and S4B). Comparison to the M. tu-
berculosis apo structure reveals a similar cavity that is
also solvent exposed (occupied by three waters) (Fig-
ure S4C). Upon binding, the QA analog supplants two
of these molecules, which fill the void in its absence
(Figure S4D). It can therefore be assumed that the
binding of NA would have a similar result, given the
similarity of the substrates and domain conservation
between these two enzyme families. The common ar-
rangement of these binding sites is further reflected in
the surrounding side chains. A sequence output from a
flexible structural alignment of the yeast NAPRTase and
the M. tuberculosis QAPRTase reveals that residues
participating in QA and NAMN binding in QAPRTases
superimpose with chemically related side chains in the
NAPRTase structure. Of 16 residues implicated in QA
or NAMN binding in the M. tuberculosis QAPRTase, 3
are fully conserved, but another 8 show some degree
of conservation based on their physicochemical prop-
erties (Figure S5). Together, these results show that the
active sites of QAPRTases and NAPRTases are struc-
turally related despite differences in relative domain ori-
entation and very low sequence similarity.
Predicted ATP Binding Site
Intensive functional examination of the NAPRTase fam-
ily has revealed that ATP increases the efficiency of ca-
talysis through autophosphorylation of a conserved
histidine residue (H232 in yNAPRTase) (Gross et al.,
1996, 1998; Rajavel et al., 1998). Attempts to visualize
the ATP binding site by cocrystallization with either ATP
or the nonhydrolyzable ATP analog AMPPNP (adeno-
sine 5#-(β,γ-imido)triphosphate) yielded only tiny micro-
crystals. Seeding these complexes increased the crys-
tal size, but failed to improve diffraction quality, as was
also the outcome for soaking experiments. To deter-
mine the possible location of the ATP binding pocket in
the yNAPRTase structure, a novel tool called SiteEngine
was employed (Shulman-Peleg et al., 2004). For this
analysis, the ATP binding motif of the M. tuberculosis
ATP PRTase (PDB: 1NH8) was selected, as this protein
binds both ATP and PRPP. The best solution for ATP
binding in the yNAPRTase structure corresponds to a
loop region (residues I389, K390, N394, L395, K397,
G400, and D401) located in domain C. Such an approxi-
mation would place H232 in direct contact with the α
phosphate, while the β and γ phosphates would interact
with residues L269 and D296, respectively (Figure 3A).
A survey of 29 NAPRTase sequences shows that the
position homologous to D296 is 100% conserved, and
that the homologous position to L269 is conserved in
all sequences, except in the NAPRTase from Vibrio cho-
lerae, where a proline is present (a leucine located four
positions toward the carboxy terminus could play the
role of L269 in that protein). The proposed location of
this binding site is consistent with previous studies
showing that domain C is solvent accessible and capa-
ble of undergoing an ATP-dependent conformationalchange that protects against proteolytic cleavage (Ra-
javel et al., 1996). In yNAPRTase, the loop region of do-
main C exists in two conformations, supporting the no-
tion of its inherent flexibility (Figure 3B). One might
envision that this loop can reorient itself into a locked
conformation upon ATP binding so as to create a local
environment that favors autophosphorylation at H232.
Addition of this ATP binding pocket is a key evolu-
tionary difference that distinguishes NAPRTases from
QAPRTases. A structural alignment between yNAPRTase
with the Salmonella typhimurium QAPRTase (PDB: 1QAP)
using the Combinatorial Extension of optimal path (CE)
method (Shindyalov and Bourne, 1998) reveals that
H232 in yNAPRTase is analogous to E214 in the
QAPRTase. Multiple sequence alignment of 20 QAPRT-
ases from bacteria, archaea, and eukarya shows that
this glutamic acid is strictly conserved (data not
shown). By comparison with the proposed catalytic
mechanisms of orotate PRTase and hypoxanthine-gua-
nine PRTase, E214 is possibly involved in stabilization
of a positively charged transition state in QAPRTases
(Eads et al., 1994). In NAPRTases, the electrostatic sta-
bilization of a positively charged intermediate via the
same mechanism would only be possible after the ad-
dition of a negative charge to H232 through autophos-
phorylation. This improved transition state stabilization
could easily translate into the ATP-dependent catalytic
stimulation observed for NAPRTases, a phenomenon
absent in QAPRTases (Hughes et al., 1993; Cao et al.,
2002). The localization of the ATP binding site to do-
main C would rationalize these findings, as QAPRTases
lack this structural element. Since tight energetic cou-
pling espouses effective catalysis in NAPRTases, the
additional regulation bestowed by domain C may fur-
ther stipulate the functional context of these enzymes
within NAD biosynthetic pathways.
Comparison of Oligomeric States
With the high degree of sequence homology among the
sandwich and barrel domains of Type II PRTases, one
would also expect their tertiary and quaternary interac-
tions to be similar. However, structural comparison of
these two enzyme families reveals distinct differences
in three-dimensional organization. A structural align-
ment of the yNAPRTase monomer with the S. typhimu-
rium QAPRTase was carried out with the CE method
(Shindyalov and Bourne, 1998). This structural align-
ment, which treats each monomer as a rigid body,
shows a tight superimposition of the barrel domains in
each structure (Figure 4A). The sandwich domains, in
contrast, occupy extremely different dispositions that
cap the barrel in the yNAPRTase structure while pro-
truding outward in QAPRTases. The alternative posi-
tioning of these segments in each enzyme facilitates
the formation of different oligomers: yNAPRTase exists
as a closed monomer, whereas all known QAPRTase
structures form head-to-tail, domain-swapped dimers
(Figures 1A and 4B; Schlunegger et al., 1997). It is feasi-
ble that this molecular pairing in QAPRTases is driven
by the formation of an open monomer coupled with the
motivation to maintain the integrity of interface con-
tacts between the barrel and sandwich domains (Fig-
ure 4B).
Structure
1390Figure 3. ATP Binding in yNAPRTase
(A) View of the predicted ATP binding site from a SiteEngine search. Loop residues of domain C (shown in magenta) help position the
adenosine ring, allowing the phosphates to extend into the barrel cavity to interact with the autophosphorylatable H232 (orange), as well as
L269 and D296 (green). AMP is modeled into the binding pocket. The bound phosphate ligand (presumably indicating the PRPP binding site)
is shown. Domains are colored as in Figure 1.
(B) Superposition of the four molecules of yNAPRTase in the asymmetric unit (colored cyan, orange, green, and white) reveals the inherent
flexibility of the domain C loop. This segment occupies two distinct conformations in the crystal (signified by a black arrow), one of which is
present in molecules A and B, the other being found in molecules C and D.Figure 4. Rigid and Flexible Alignments of yNAPRTase and S. typhimurium QAPRTase Monomers
(A) Rigid structural alignment using the CE method. The yNAPRTase monomer (PDB: 1VLP) is colored cyan, the S. typhimurium monomer
(PDB: 1QAP) is colored orange.
(B) Head-to-tail dimeric arrangement common to QAPRTases. The S. typhimurium dimer is shown with monomers colored blue and yellow
to differentiate. The black line indicates the preservation of interdomain contacts found in the yNAPRTase monomer through domain swapping
(compare to Figure 1A).
(C) Flexible structural alignment of monomers by using FATCAT. Monomers are colored as in (A).
(D) Location of the four twists (denoted as black arrows) introduced into the QAPRTase monomer that facilitate agreement of the two
structures by flexible alignment.
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1391FATCAT (Ye and Godzik, 2003), an alternative struc-
tural alignment method that permits mobility in and
between structural components, reveals a common ar-
chitectural blueprint that transcends domain organiza-
tional differences (Figures 4C and 4D). This flexible ap-
proach significantly improves the alignment of the two
structures by introducing four twists in the QAPRTase
structure. The twist points used for manipulation (ar-
rows), which are depicted in a rainbow scheme in Fig-
ure 4D, occur between five conserved regions in the
QAPRTase structure. The first twist, shown in black, is
located in a nonconserved linker between the red
and orange segments. The second twist, also colored
black, contains nonconserved residues linking the or-
ange and yellow sections of the sandwich domain. The
final two twists occur at the bend of the long α helix
that connects the two domains and within the barrel
structure in β7. The result is a robust matching of the
key structural elements between the two enzymes, with
only minor gaps in the alignment.
In NAPRTases, domains A and B are permanently in
close contact, and the enzymatic activity is modulat-
ed by domain C-dependent autophosphorylation. In
QAPRTases, where this regulation is absent, it is tempt-
ing to speculate that the control of the enzymatic
activity might be accomplished through a monomer (in-
active)-to-dimer (active) transition driven by the interac-
tion between the A and B domains. Such transitions in
oligomeric state have been observed in other PRTases,
such as uracil PRTase (Jensen et al., 1997) and anthran-
ilate 5-PRPP PRTase (Marcus and Balbinder, 1972).
Implications for Other NAD Salvage Enzymes
The architectural distinctions highlighted by the
yNAPRTase structure raise an important question: how
well do these features extend to other salvage enzymes
involved in NAD recycling? As illustrated in Figure 1, an
additional recycling route produces NAD from NM in a
two-step mechanism mediated by NMPRTases. Little is
known about the structure and function of this enzyme
family, although it has been linked to lymphocyte acti-
vation and transcriptional regulation via Sir2 proteins
(Rongvaux et al., 2002; Revollo et al., 2004). To deter-
mine whether NMPRTases have any structural homol-
ogy to the other NAD biosynthetic PRTases, a BLAST
search with the mouse NMPRTase sequence (GenBank:
GI:10946948) against the PDB database was per-
formed. No significant matches were obtained (the best
expectation value was 1.2). Therefore, we resorted to
using the Fold and Function Assignment System
(FFAS03), a sensitive profile-profile fold recognitionTable 2. FFAS03 Search Results for NMPRT
Enzyme PDB Code Score Identity
Saccharomyces cerevisiae NAPRTase 1VLP −65.0 14%
Helicobacter pylori QAPRTase 1S41 −28.5 10%
Salmonella typhimurium QAPRTase 1QAP −24.9 13%
Mycobacterium tuberculosis QAPRTase 1QPN −24.1 16%
Thermotoga maritima QAPRTase 1O4U −19.9 10%
The FFAS03 search was performed by using the sequence of mouse NMPRTase as query. A score of −9.5 is the significance threshold for
this tool, indicating that less than 3% of the matches are false positives. The more negative the score, the better the match.method (Rychlewski et al., 2000), to search the mouse
NMPRTase sequence against the PDB database. This
technique, which utilizes entire homologous families to
create protein profiles for a matching algorithm, is able
to detect distant homologies that are often missed due
to low sequence identity. The results for this search are
illustrated in Table 2, with a more negative score signi-
fying a better statistical match between a query se-
quence and a characterized fold. The typical signifi-
cance threshold is −9.5, which indicates that less than
3% of the matches are false positives. Of all possible
protein folds, the best match for the NMPRTase is the
yNAPRTase monomer, with a score of −65.00 (14% se-
quence identity). More distant fold matches also occur
with the four known QAPRTase structures (Table 2),
which can be expected due to the common structural
domains among Type II PRTases. The implication of
this finding is that NMPRTases can be classified as
Type II PRTases and suggests that they are more likely
to adopt the closed monomer configuration of NAPRT-
ases, with whom they are more closely related. Based
on this hypothesis, the yNAPRTase structure was em-
ployed as a template to generate a homology structural
model for the NMPRTase (Figure 5A) by using the pro-
gram Modeller (Fiser and Sali, 2003) and the FFAS03
alignment (Figure S2A).
The homology model of the mouse NMPRTase pro-
vides two key insights into the structural properties of
Type II PRTases. First, it helps further define a con-
served tripartite sequence motif that forms the inter-
face between domains A and B (Figure S2B). This con-
sensus site is reasonably well conserved between all
three families, with diverging residues showing a
greater degree of similarity within each individual en-
zyme type. These contacts are maintained indepen-
dently of the oligomeric state. It is feasible that given
the irregular arrangement of the barrel, this interface
serves to position the sandwich domain in such a way
as to close off the gap between strands β2–β3, thereby
ensuring the fidelity of the active site. Second, the
mouse NMPRTase possesses an additional sequence
at the C terminus that corresponds to domain C in
yNAPRTase. This segment, which is not present in
QAPRTases, is predicted to occupy the same position
in both proteins—extending out from above the barrel
core (Figure 5A); whether this domain imparts a similar
ATP-dependent energetic coupling in NMPRTases or an
alternative function is still unclear. In humans, two alter-
natively spliced isoforms of the NMPRTase gene are
distinguished by the presence or absence of this do-
main C-like element. These are conceptually repre-
sented in Figure 5B. Isoform a is 491 amino acids in
Structure
1392Figure 5. Homology Modeling of NMPRTase
(A) Homology model of the mouse
NMPRTase (magenta) generated with the
program Modeller and threaded onto the
yNAPRTase structure (cyan).
(B) Homology models for the two human
NMPRTase isoforms, also generated with
Modeller. The structure on the left represents
the truncated splice variant lacking the do-
main C equivalent. The structure on the right
depicts the full-length version of the enzyme
with the additional sequence at the C terminus
similar to yNAPRTase (highlighted in yellow).length, with 95% identity to the mouse enzyme, while
isoform b is 364 residues long and lacks the final
C-terminal region. In spite of this truncation, several
identical matches to each protein variant exist in the
Genbank EST database (dbEST), indicating that each is
expressed. The absence of domain C further indicates
that the NMPRTase may function efficiently without the
requirement of energetic coupling.
Molecular Evolution of Type II PRTases
NAPRTases are monomeric Type II PRTases with impor-
tant structural similarities to QAPRTases, which sug-
gests a common lineage. Multiple sequence alignments
show that NAPRTases and NMPRTases have more in-
sertions than QAPRTases. It is commonly thought that
proteins become longer and more complex than their
ancestral progenitors as they evolve (Li, 1997; Wang et
al., 2005), providing opportunities for functional improve-
ment (Matsuura et al., 1999; Trifonov and Berezovsky,
2003). Insertion distribution implies that NMPRTases
are more “modern” than NAPRTases, which in turn are
more “modern” than QAPRTases. Fold recognition meth-
ods applied to the α/β barrel domain indicate that thia-
mine phosphate synthase (TMP-PPase; PDB: 1G69) is
the closest structural homolog. The use of a pyrophos-
phate substrate and a catalytic mechanism involving
the formation of a carbocation intermediate are addi-
tional points of similarity between PRTases and TMP-
PPase (Peapus et al., 2001). Rooted phylogenetic trees
with TMP-PPase as an outgroup suggest again that
QAPRTases are the most divergent family, followed by
NAPRTases and NMPRTases (Figure S3). The α + β
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pandwich domain is similar to several single domain
ransferases. Trees built with the sandwich domain of
RTases show the same topology as those built with
he barrel domain. Taxonomic distribution and the
cquisition of progressively longer versions of domain
also support a latter divergence of NMPRTases with
espect to NAPRTases.
Based on these lines of evidence, we propose a
odel for the molecular evolution of Type II PRTases
Figure 6). The fact that the sandwich domain is split
nto two parts in PRTases suggests that an ancestral
pen enzyme might have arisen from the insertion of
n α/β barrel domain into a two-layer sandwich trans-
erase (Figure 6, red arrow), and subsequently stabi-
ized through domain-swapping dimerization. From this
ncestral form, the development of new Type II
RTases is likely driven by gene duplication. This is
uggested by the presence of paralogous NAPRTases,
MPRTases, and QAPRTases in humans and other or-
anisms. Gene duplication allows existing genes to
volve new functions and fine tune biological pro-
esses. In Type II PRTases, such actions afforded the
cquisition of two new complementary salvage enzy-
atic activities, thus considerably improving NAD ho-
eostasis. The addition of a regulatory element (do-
ain C) communicates a tight energetic coupling to
APRTase catalysis and presumably a different set of
estraints on NMPRTase activities. This final constituent
hows high variability and possibly plays a number of
egulatory roles on the enzymatic activity of NAPRTase
nd NMPRTase, as illustrated by the presence of multi-
le NAPRTase and NMPRTase isoforms in humans that
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1393Figure 6. Proposed Model for the Molecular Evolution of Type II PRTasesdiffer mainly in the length and absence/presence of
domain C.
Experimental Procedures
Cloning, Expression, and Purification
yNAPRTase was amplified by PCR from genomic DNA from S. cere-
visiae by using PfuTurbo (Stratagene) and primer pairs encoding the
predicted 5# and 3# ends of yNAPRTase. The PCR product was cloned
into plasmid pMH1, which encodes an expression and purification
tag (MGSDKIHHHHHH) at the amino terminus of the full-length pro-
tein. The cloning junctions were confirmed by sequencing. Protein
expression was performed in a selenomethionine-containing me-
dium by using the E. coli methionine auxotrophic strain DL41. Bac-
teria were lysed by sonication in lysis buffer (50 mM K2HPO4 [pH
7.8], 300 mM NaCl, 10% glycerol, 5 mM imidazole, Roche EDTA-
free protease inhibitor tablets) with 0.5 mg/ml lysozyme. Immedi-
ately after sonication, the cell debris was pelleted by ultracentrifu-
gation at 60,000 × g for 20 min (4°C). The soluble fraction was
applied to a gravity flow metal chelate column (Talon resin charged
with cobalt; Clontech) equilibrated in lysis buffer. The column was
then washed with 7 column volumes (CV) of wash buffer (20 mMTris [pH 7.8], 300mM NaCl, 10% glycerol, 10 mM imidazole) and
eluted with 3 CV of elute buffer (25 mM Tris [pH 7.8], 300 mM NaCl,
150 mM imidazole). The protein was then buffer exchanged into
crystallization buffer (10 mM Tris [pH 7.8], 150 mM NaCl) and con-
centrated by centrifugal ultrafiltration (Orbital). The protein was
either frozen in liquid nitrogen for later use or was used immedi-
ately for crystallization trials.
Crystallization
The protein was crystallized by using the nanodroplet vapor diffu-
sion method (Santarsiero et al., 2002) with standard JCSG crystalli-
zation protocols (Lesley et al., 2002). Crystals were grown at 4°C by
using 6%–16% PEG 5000 MME, 0.06 M MES, and 0.04 M NaMES at
pH 6 with a protein concentration of 10–30 mg/ml 15–20% ethylene
glycol was used as a cryoprotectant for freezing. The crystals were
indexed in the triclinic space group P1 (Table 1).
Data Collection
MAD diffraction data sets, in addition to a 1.75 Å high-resolution
data set (λ0 = 0.9686), were collected at wavelengths correspond-
ing to the inflection point (λ1 = 0.9798) and the low-energy remote
(λ2 = 1.0332) (Table 1). The data sets were collected at 100 K by
Structure
1394using ADSC 210 and 315 CCD detectors at beamlines 8.2.1 and
8.2.2, respectively, of the Advanced Light Source (ALS, Berkeley,
CA, USA). Data were integrated and reduced by using HKL2000
(Otwinowski and Minor, 1997). Data statistics are summarized in
Table 1.
Structure Solution and Refinement
The heavy-atom sites were found by using SHELXD (Schneider and
Sheldrick, 2002) and were refined with autoSHARP (de La Fortelle
and Bricogne, 1997; C. Vonrhein et al., personal communication) by
using the inflection and remote wavelength data from 50 Å to 3.0 Å.
The peak wavelength of the MAD data suffers from radiation dam-
age and was not used in the phasing. The experimental phases
were improved, and an initial trace was obtained by using RE-
SOLVE (Terwilliger and Berendzen, 1999). The trace was further im-
proved with wARP (Perrakis et al., 1997) from the RESOLVE model
by using the 1.75 Å data set. Structure refinement (including TLS
refinement) was carried out at 1.75 Å by using REFMAC5 (CCP4,
1994; Winn et al., 2001), O (Jones et al., 1991), and Xfit (McRee,
1999). Refinement statistics are summarized in Table 1. The final
model includes four protein monomers (residues −1–415 for mole-
cule A, residues 1–419 for molecule B, residues −1–416 for mole-
cule C, and residues 0–415 for molecule D), four bound phosphate
molecules, three ethylene glycol molecules, one molecule of mor-
pholineethanesulfonic acid (MES), three chloride ions, and 1272
water molecules in the asymmetric unit. No electron density was
observed for residues 416–429 in molecule A, residues 420–429 in
molecule B, residues 417–429 in molecule C, residues 416–429 in
molecule D, or for the rest of the expression and purification tags
besides those residues already denoted (residues −1 and 0).
Structure Analysis
Analysis of the stereochemical quality of the model was accom-
plished by using the AutoDepInputTool (http://deposit.pdb.org/
adit/), MolProbity (Lovell et al., 2003), SFcheck 4.0 (Vaguine et al.,
1999), and WHAT IF 5.0 (Vriend, 1990). Protein quaternary structure
analysis used the PQS server (http://pqs.ebi.ac.uk/; Henrick and
Thornton, 1998).
Biocomputational Methods
Sets of NAPRTases, QAPRTases, and NMPRTases were generated
through similarity searches performed with PSI-BLAST (Altschul et
al., 1997). The sequences of S. cerevisiae NAPRTase (SwissProt:
P39683), Thermotoga maritima QAPRTase (SwissProt: Q9X1X8),
and mouse NMPRTase (GenBank: GI:50293167) were used as que-
ries. Two PSI-BLAST iterations were performed against the NCBI
nonredundant database. BLOSUM62 was the weight matrix, the
expectation value threshold for inclusion of sequences into a pro-
file was 0.01, and no low-complexity filtering was used. Sequence-
based multiple sequence alignments were produced by using the
ClustalX implementation of ClustalW 1.8 (Higgins et al., 1994) and
the program T-Coffee (Notredame et al., 2000). Multiple sequence
alignments integrating sequence and structural data were gener-
ated by using the program 3D-Coffee (O’Sullivan et al., 2004). The
alignments were visualized, manually curated, and evaluated for
residue conservation with the Genedoc sequence alignment editor
(Nicholas et al., 1997). Phylogenetic trees were produced by using
the Neighbor-Joining method as implemented in ClustalX. Posi-
tions with gaps in the multiple sequence alignments were ignored
during tree construction. Confidence values for the groupings in
the trees were obtained by applying 1000 cycles of bootstrapping.
PDB structures were visualized, and molecular graphics, including
both ribbon representations and surface graphics, were composed
with Discovery Studio ViewerPro 5.0 (Accelrys). Rigid and flexible
pairwise structural alignments were created by using the programs
CE (Shindyalov and Bourne, 1998) and FATCAT (Ye and Godzik,
2003). Multiple structures were aligned simultaneously by using
the program MASS (Dror et al., 2003). The profile-profile method
FFAS03 (Rychlewski et al., 2000) was used for fold recognition, to
search for distant homologs, and sequence alignment when se-
quence-sequence or sequence-profile methods did not yield statis-
tically significant results. The structural homology model of mouse
NMPRTase was built by using the program Modeller (Fiser and Sali,
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D003); the FFAS03 alignment of the mouse NMPRTase and
NAPRTase as alignment input, and the structure of the
NAPRTase was used as a structural template. The information
hown in Figure 1 was derived from KEGG (Kanehisa et al., 2004)
etabolic maps combined with enzymatic information from the
RENDA enzyme database (Schomburg et al., 2004). The potential
TP binding site in the yNAPRTase was predicted by using Site-
ngine (Shulman-Peleg et al., 2004). EST searches were performed
y using TBLASTN against the GenBank dbEST database and its
uman and mouse sections (Boguski et al., 1993).
upplemental Data
upplemental Data including a steroview and a wire diagram of the
econdary structure of yNAPRTase, active site occupancies and
onservation, the template-target sequence alignment used to
uild the homology model of NMPRTase, and phylogenetic analysis
sed to propose the molecular evolution model of the Type II
RTase family are available at http://www.structure.org/cgi/content/
ull/13/9/1385/DC1.
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